CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 322037-322180 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2468","span":{"begin":0,"end":143},"obj":"Sentence"},{"id":"T2645","span":{"begin":0,"end":143},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A group formed by serotypes [11, 15, 33, 35] is also more likely to increase in prevalence, OR 2.4, 1.3−4.5, p = 0.01) than other NV serotypes."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T204","span":{"begin":0,"end":143},"obj":"Sentence"}],"text":"A group formed by serotypes [11, 15, 33, 35] is also more likely to increase in prevalence, OR 2.4, 1.3−4.5, p = 0.01) than other NV serotypes."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T689","span":{"begin":0,"end":143},"obj":"Epistemic_statement"}],"text":"A group formed by serotypes [11, 15, 33, 35] is also more likely to increase in prevalence, OR 2.4, 1.3−4.5, p = 0.01) than other NV serotypes."}